Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha
about
Skeletal muscle PGC-1α is required for maintaining an acute LPS-induced TNFα responseMetalloprotease-disintegrin MDC9: intracellular maturation and catalytic activityCloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS familyEvidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2betaInteraction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinasesSPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 productionTumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cellsAn aminopeptidase, ARTS-1, is required for interleukin-6 receptor sheddingIdentification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain sheddingEvidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1Integrin alpha5beta1 and ADAM-17 interact in vitro and co-localize in migrating HeLa cellsTumor necrosis factor-alpha converting enzyme in the human placenta throughout gestationMetalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brainPolymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cellsAtaxia and peripheral nerve hypomyelination in ADAM22-deficient miceExtracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding.Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzymeADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanismADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and functionMutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasiaThe cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreadingTumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel diseaseEctodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healingCrystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzymeADAM17 deficiency by mature neutrophils has differential effects on L-selectin sheddingAggrecanases and cartilage matrix degradationAlcohol reversibly disrupts TNF-alpha/TACE interactions in the cell membraneGeneration of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during InflammationADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural OverviewA Disintegrin and Metalloprotease (ADAM): Historical Overview of Their FunctionsRecent advances in the field of anti-cancer immunotherapyAdvances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2Anti-TNF therapy for juvenile idiopathic arthritis-related uveitisBreast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticityStudies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to dateSoluble TNF mediates the transition from pulmonary inflammation to fibrosisPhosphatidylserine exposure is required for ADAM17 sheddase function
P2860
Q21134754-86AEAB27-57AE-412C-8D4A-FD2677EB4A3EQ22008720-6D8F5519-9786-4209-A53F-737BA12E4957Q22010479-1B00DF67-D769-448C-873C-05A84EFE9F40Q22010696-DC1298A2-FB68-4549-8E15-E1B0F9308F15Q22010715-5315221E-2E3B-47C3-B250-7CAC1D681D01Q24291999-11453448-B97D-4CAD-A664-AC1336D2A372Q24296666-83BA067D-93B9-47FA-BDB8-9C7B16D755ADQ24300017-C4E2E352-B468-49EC-9949-49EBF0375391Q24301863-182A1DC6-5EE9-4E5E-9A22-40A4A456B7F9Q24305047-C1689373-2413-41EC-8C7C-336DC644F83CQ24305944-C9D22337-9E8E-43DA-B645-8868AD91747EQ24309589-DB0D51FE-EBE5-46CA-9650-7B1397045DBBQ24314291-9EBCD82D-6326-4832-AACB-85BF8AAFD0FBQ24321609-BD39FABB-828A-4154-9060-1F7B51296775Q24336346-43271B89-3DE4-4527-A2EC-BAC60AB94845Q24529106-81257CD9-DFD0-4397-A8BB-765AB028506EQ24531403-A1AA036E-7791-43B3-8B67-F374A8F39B82Q24532037-D3A34006-A8BC-42F4-92D0-77ECA0805B4AQ24533465-CBA5C3AC-B981-4393-975E-AF76D6AB3E8DQ24534110-7509E2FF-D8EB-48F6-A15E-B4C6786A68D8Q24548850-32ED5DAB-C58A-4823-B996-AEF3DD626DFAQ24618923-8C4E963E-A7D7-4984-A4C8-50C92CFD4F38Q24631099-D6CCCE7B-0326-462A-8BF5-A847D3D9BED2Q24669779-E9E2AC89-047B-4D1E-912E-900ACF1805CBQ24669999-631387B1-3C8E-408F-866A-B3ED27F3961CQ24677883-6BB54B5E-BD62-405D-8BCC-340975CDBEE9Q24682970-57713CB4-2594-4A74-AE15-29417D382173Q24685839-498CC5B8-EDF2-4B49-B263-4CA76078EDAAQ24804310-CA67A93D-B0DB-4E94-B73F-E04594F499C2Q24812187-FA54C045-4894-4DAD-B77D-CBF3A6B79394Q26738992-45CCEB10-F3FC-4E61-9BD1-A7E18C528875Q26747656-7FA72DFD-BF96-42A8-BBEF-3CBEFB71B2F2Q26749364-517F8AC4-4156-46AC-891C-3ED466C059D7Q26775602-528230AF-1175-44B6-B739-076A34E7CC6DQ26798299-9E86568F-8B55-4DCB-B387-A8F05CA09A44Q26849811-08B794C9-3B36-43CC-AA32-89741D48A8A9Q26851620-8FCE235B-4E85-445C-8602-B4E2BCB0F783Q27001147-494288CF-1C7F-4A8D-A7AD-63C6AAE849C2Q27303153-DE4178AC-08DD-4EB6-B338-B3A790E5DE6DQ27317119-EBE87882-4F89-4D5E-A2FA-D075C95BD773
P2860
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@ast
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@en
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@en-gb
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@nl
type
label
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@ast
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@en
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@en-gb
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@nl
prefLabel
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@ast
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@en
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@en-gb
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@nl
P2093
P921
P3181
P356
P1433
P1476
Cloning of a disintegrin metal ...... r tumour-necrosis factor-alpha
@en
P2093
C R Hoffman
D M Bickett
F Schoenen
G McGeehan
H L Carter
J D Becherer
J Mitchell
P2888
P3181
P356
10.1038/385733A0
P407
P577
1997-02-20T00:00:00Z
P6179
1033291268